Transient Suppression of Atopy in Early Childhood Is Associated With High Vaccination Coverage

Vaccination News Home Page                                            subscribe Vaccination NewsLetter

 

 

http://www.pediatrics.org/cgi/content/abstract/111/3/e282

 

 

PEDIATRICS Vol. 111 No. 3 March 2003, pp. e282-e288

 

—————————————

 

ELECTRONIC ARTICLE

 

Transient Suppression of Atopy in Early Childhood Is Associated With High Vaccination Coverage

 

Christoph Grüber, MD*, Sabina Illi, MPH, Susanne Lau, MD, PhD*, Renate Nickel, MD*, Johannes Forster, MD, PhD, Wolfgang Kamin, MD||, Carl-Peter Bauer, MD, PhD¶, Volker Wahn, MD, PhD# and Ulrich Wahn, MD, PhD* MAS-90 Study Group

 

* Department of Pediatric Pneumology and Immunology, Charité-Humboldt University, Berlin, Germany

 Department of Pulmonology and Allergology, Ludwig Maximilians University, Munich, Germany

 St. Hedwig Hospital, Freiburg/Breisgau, Germany

|| Department of Pediatric Pneumology, Johannes Gutenberg University, Mainz, Germany

¶ University Children’s Hospital, Technical University, Munich, Germany

# Klinikum Uckermark, Schwedt/Oder, Germany

 

Objective. To analyze prevalences of allergic sensitization and atopic disease in relation to vaccination coverage.

 

Methods. A German atopy risk-enhanced birth cohort of 1314 neonates who were born in 1990 in 5 German cities was studied. A total of 943 children participated in the follow-up visit at 5 years of age. Atopic symptoms and diagnoses (derived from structured interviews), total serum immunoglobulin E, and specific immunoglobulin E against 9 common allergens (CAP Radio-Allergo-Sorbent Test Fluoro-Enzyme Immunoassay) were evaluated. Children were grouped into dose percentiles according to cumulative doses of any vaccine given up to 5 years of age (<10%, 0–11 doses; 10%–50%, 12–14 doses; 51%–90%, 15–20 doses; >90%, 21–27 doses).

 

Results. The cumulative vaccine dose was inversely related to atopic dermatitis prevalences at 6 months (13.8%, 5.2%, 5.1%, and 4.5%), 2 years (16.9%, 10.9%, 7.4%, and 3.7%), 3 years (27.6%, 16.4%, 13.5%, and 4.5%), and 5 years (28.3%, 16.0%, 9.3%, and 11.9%). Asthma followed a similar pattern at age 3 (22.4%, 8.6%, 6.7%, and 6.3%), age 4 (20.0%, 8.6%, 8.9%, and 8.1%), and age 5 (20.8%, 12.6%, 10.3%, and 5.5%). Allergic sensitization rates were inversely related to the cumulative vaccine dose at age 2 (37.5%, 29.1%, 23.8%, and 12.9%).

 

Conclusion. Children with a higher vaccination coverage seemed to be transiently better protected against development of atopy in the first years of life.

 

 

Key Words: child • preschool • vaccination • asthma • atopic dermatitis • immunoglobulin E

 

 

Abbreviations: IgE, immunoglobulin E • OR, odds ratio • CI, confidence interval

 

——————————————————————————

Received for publication May 16, 2002; accepted Nov 20, 2002.

 

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.